Legend Biotech (LEGN) EBT Margin (2019 - 2025)

Legend Biotech (LEGN) posted EBT Margin of 6.4% for Q4 2025, up 55.4% quarter-over-quarter from 14.35% in Q3 2025, and down 2811.0% year-on-year from 0.24% in Q4 2024.

Legend Biotech (LEGN) EBT Margin (2019 - 2025) Analysis & Trends

Legend Biotech (LEGN) has reported EBT Margin for 7 consecutive years, with 6.4% the latest figure, recorded in Q4 2025.

  • EBT Margin for Q4 2025 came in at 6.4%, down 2811.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 27.47% (down 226.0% YoY), and the FY2025 annual result was 27.47%, down 226.0% from the prior year.
  • EBT Margin was 6.4% for Q4 2025 at Legend Biotech, up from 14.35% in the prior quarter.
  • Over five years, EBT Margin peaked at 1956.06% in Q3 2022 and troughed at 1612.82% in Q2 2022.
  • Average EBT Margin over 5 years is 101.76%, with a median of 57.22% recorded in 2024.
  • The widest YoY moves for EBT Margin: up 269502 bps in 2022, down 246577 bps in 2022.
  • Over 5 years, EBT Margin stood at 1044.23% in 2021, then soared by 53 bps to 491.16% in 2022, then jumped by 100 bps to 0.18% in 2023, then jumped by 11854 bps to 21.72% in 2024, then sank by 129 bps to 6.4% in 2025.
  • Per Business Quant data, the three most recent EBT Margin figures were 6.4% in Q4 2025, 14.35% in Q3 2025, and 48.93% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 8.26%
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - -
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 17.13%
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 41.95%
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn -6.78%
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 23.05%
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 33.74%
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 18.99%
9 Revolution Medicines 37.15 Bn 37.15 Bn - -
10 Legend Biotech 11.04 Bn 10.14 Bn 242.10 Mn -6.43%

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.43%
Sep 30, 2025 -14.35%
Jun 30, 2025 -48.93%
Mar 31, 2025 -50.82%
Dec 31, 2024 21.77%
Sep 30, 2024 -75.46%
Jun 30, 2024 -9.63%
Mar 31, 2024 -63.61%
Dec 31, 2023 -0.18%
Sep 30, 2023 -712.53%
Jun 30, 2023 576.55%
Mar 31, 2023 -308.16%
Dec 31, 2022 -491.16%
Sep 30, 2022 1,956.06%
Jun 30, 2022 -1,612.82%
Mar 31, 2022 -64.20%
Dec 31, 2021 -226.53%
Sep 30, 2021 -738.96%
Jun 30, 2021 -852.01%
Mar 31, 2021 -0.69%